- FDA approved the vaccine for children on Tuesday.
- Children from 5 to 11 years old will be able to start receiving the vaccine in the next few weeks.
- CDC will also need to recommend the vaccine for children before it can be widely available.
The FDA approved the Covid-19 vaccine for children ages 5 to 11 on Tuesday. If also recommended by the CDC, children could begin receiving the vaccine next week.
A study published by the FDA, reported that the vaccine had proven to be very effective in protecting children from the virus. Therefore, the Centers for Disease Control and Prevention are expected to approve this initiative.
THE VACCINE IS APPROVED FOR CHILDREN AGES 5 TO 11
According to Agencia EFE, this Tuesday it was announced that an advisory committee of the United States Food and Drug Administration (FDA) recommended the approval for emergency use of Pfizer’s Covid-19 vaccine for children between 5 and 11 years old. This news comes after reports of an increase in infections in children under 17 was announced.
Meanwhile, the New York Post reported that now that the vaccine has been approved for children between 5 and 11 years old, it could become available to the public by the first or second week of November; experts hope that all parents will vaccinate their children in order to keep the virus under control.
FDA Approves Children’s Vaccine: The Obstacles That Have Been Recorded
The Agencia EFE reported that after a seven hour meeting, experts have given the green light to the recommendation, with 17 votes in favor and one abstention. This was one of the first obstacles that the to the final approval of this initiative.
The EFE also mentioned that the committee has to vote yes or no on the question of whether the benefits of Pfizer’s vaccine outweigh the risks in children between the ages of 5 and 11. Although there were some no votes, it is expected that the vaccine could reach the public in the coming weeks. Filed Under: FDA Approves Children’s Vaccine
FDA Approves Children’s Vaccine: Next Steps
The New York Post announced that the Food and Drug Administration must now consider formal approval of the vaccine, therefore, it is expected that in the next few days they will meet to vote on how to proceed with the administration of the Pfizer vaccine in children ages 5 to 11.
The next step towards approval of the vaccine is recommendation by the CDC. According to sources, if the Pfizer vaccine for children gets this approval there will be no more obstacles for its administration to children who will finally be protected from the virus. Filed Under: FDA Approves Children’s Vaccine
FDA Approves Children’s Vaccine: CDC Approval
According to the New York Post, an advisory panel from the Centers for Disease Control and Prevention is ready to consider approval of the vaccine on November 2; this would be the last step for the children to begin receiving the Pfizer vaccine in the coming days.
They will meet on November 3 to further examine Pfizer’s vaccine data for children ages 5 to 11, before that agency’s director, Rochelle Walenksy, has the final say on the matter. The FDA hopes the proposal will be accepted by the CDC director. Filed Under: FDA Approves Children’s Vaccine
FDA Approves Children’s Vaccine: An Issue of National Interest, Will the Virus Evolve?
One of the biggest concerns for experts that the virus can continue to mutate. For this reason, by proving the efficacy of the Pfizer vaccine in minors, they hope that the vast majority of children who are vulnerable can be protected.
According to the Agencia EFE, during Tuesday’s session, expert Hong Yang, Risk-Benefit Assessment Advisor for the FDA Office of Biostatistics and Epidemiology, discussed various possible scenarios for the evolution of the pandemic. Therefore, they want this vaccine to be approved in the coming days. Filed Under: FDA Approves Children’s Vaccine
FDA Approves Children’s Vaccine: Are There Possible Dangers?
The Agencia EFE also pointed out that in all cases, the benefits of immunizing children “clearly” outweigh the risks, Yang said, citing myocarditis, an inflammation of the heart, as one of the possible dangers. Although, it is expected that very few children will actually be at risk.
As reported by the agency, Yang indicated that, although there is a theoretical increased risk of myocarditis in vaccinated children, especially in boys, the benefits of being immunized seem to remain “strong”. Filed Under: FDA Approves Children’s Vaccine
No ‘serious’ cases
The Agencia EFE reported that CDC pediatrician Matthew Oster, who also spoke at the committee meeting, noted that they have not detected higher rates of myocarditis caused by vaccines among children 12 to 17 years old. For this reason, it is expected that in minors between 5 and 11 years old, this risk will be nonexistent.
In May, the United States gave the green light to the Pfizer injection for adolescents 12 years and older. Oster explained that myocarditis can occur in minors with multisystemic inflammatory syndrome caused by COVID-19; in approved studies, it was reported that there is less risk after getting the shot.
How the plan to vaccinate children ages 5 to 11 started
Advisers from the US Centers for Disease Control and Prevention (CDC) will meet on November 2-3 and are expected to give their approval. Once that has happened, doses will begin shipping to providers across the country, along with smaller needles, and vaccines will be available on a large scale within days.
“We are completing operational planning to ensure that vaccines for children ages 5 to 11 are available, easy and convenient,” White House COVID-19 coordinator Jeff Zients said Wednesday, according to The Associated Press.
28 million eligible children
The Biden administration has stressed that the new plan to extend vaccination protection to the school-age population will not look like 10 months ago, when the country first began administering vaccines when shortages and capacity issues meant a long wait for many Americans.
The country now has an ample supply of Pfizer vaccine for the roughly 28 million children who will soon be eligible to receive it, White House officials said, and they have been working for months to ensure the widespread availability of the vaccines once approved.
White House encourages vaccination
More than 25,000 pediatricians and primary care providers have already signed up to administer the COVID-19 vaccine to children, the White House said, in addition to the tens of thousands of pharmacies already giving injections to adults. The Federal Emergency Management Agency will also fund and support hundreds of school and community clinics to accelerate the campaign.
The White House is also preparing an intensified campaign to educate parents and children about the safety of vaccines and the ease of obtaining them. As has been the case with adult vaccines, the federal government believes that trusted messengers – educators, physicians, and community leaders – will be vital in promoting vaccination.
Vaccination reduces risks of COVID-19 side effects
Although children are less at risk than older people of having serious side effects of COVID-19, they can occur, and authorities say vaccination drastically reduces those chances and will reduce community spread of the delta variant, which is more transmissible, and will lead to a faster recovery of the nation from the pandemic.
“COVID has also altered the lives of our children. It has made school more difficult, it has disrupted their ability to see friends and family, it has made youth sports more challenging,” US Surgeon General Dr. Vivek Murthy told NBC on Wednesday. “By vaccinating our children, we have the perspective of protecting them, but also recovering all those activities that are so important to our children,” he added.